Anti-Cyclin D1 Picoband antibody, PB9370, Western blotting All lanes: Anti Cyclin D1 (PB9370) at 0.5ug/ml Lane 1: Human Placenta Tissue Lysate at 50ug Lane 2: HELA Whole Cell Lysate at 40ug Lane 3: 293T Whole Cell Lysate at 40ug Predicted bind size: 33KD Observed bind size: 33KD
Anti-Cyclin D1 Picoband antibody, PB9370, Western blotting All lanes: Anti Cyclin D1 (PB9370) at 0.5ug/ml Lane 1: Human Placenta Tissue Lysate at 50ug Lane 2: HELA Whole Cell Lysate at 40ug Lane 3: 293T Whole Cell Lysate at 40ug Predicted bind size: 33KD Observed bind size: 33KD
Anti-Cyclin D1/CCND1 Antibody Picoband(r)
PB9370
ApplicationsWestern Blot
Product group Antibodies
TargetCCND1
Overview
- SupplierBoster Bio
- Product NameAnti-Cyclin D1 Picoband Antibody
- Delivery Days Customer9
- Application Supplier NoteWB: The detection limit for Cyclin D1 is approximately 0.1ng/lane under reducing conditions. Tested Species: In-house tested species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration500 ug/ml
- Gene ID595
- Target nameCCND1
- Target descriptioncyclin D1
- Target synonymsBCL1, D11S287E, PRAD1, U21B31, G1/S-specific cyclin-D1, B-cell CLL/lymphoma 1, B-cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene
- HostRabbit
- IsotypeIgG
- Protein IDP24385
- Protein NameG1/S-specific cyclin-D1
- Scientific DescriptionBoster Bio Anti-Cyclin D1/CCND1 Antibody Picoband® catalog # PB9370. Tested in WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203
References
- He Y, Liu HH, Zhou XL, et al. Rutaecarpine Ameliorates Murine N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway. Molecules. 2023,28(17). doi: 10.3390/molecules28176294Read this paper
- Lei S, Du X, Tan K, et al. CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling. Exp Ther Med. 2023,26(1):314. doi: 10.3892/etm.2023.12013Read this paper
- Dong C, Huang S, Sun L, et al. DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression. Sci Rep. 2022,12(1):19775. doi: 10.1038/s41598-022-23837-yRead this paper
- Chen T, Feng G, Xing Z, et al. Circ-EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/β-catenin pathway through the miR-1253/NOVA2 axis. Thorac Cancer. 2022,13(22):3133-3144. doi: 10.1111/1759-7714.14665Read this paper
- Bai X, Liu X, Li S, et al. Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer. J Agric Food Chem. 2022,70(12):3687-3696. doi: 10.1021/acs.jafc.1c08375Read this paper
- Zhang X, Chen R, Song LD, et al. SIRT6 Promotes the Progression of Prostate Cancer via Regulating the Wnt/β-Catenin Signaling Pathway. J Oncol. 2022,2022:2174758. doi: 10.1155/2022/2174758Read this paper
- Sun M, Zhou D, Wu J, et al. Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway. Mar Drugs. 2022,20(2). doi: 10.3390/md20020125Read this paper
- Wang X, Xie Z, Lou Z, et al. Regulation of the PTEN/PI3K/AKT pathway in RCC using the active compounds of natural products in vitro. Mol Med Rep. 2021,24(5):pii: 766. doi: 10.3892/mmr.2021.12406.Read this paper
- Lu Z, Song W, Zhang Y, et al. Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer. Front Oncol. 2021,11:648985. doi: 10.3389/fonc.2021.648985Read this paper
- Sanches JGP, Song B, Zhang Q, et al. The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT Pathway. Front Oncol. 2021,11:637298. doi: 10.3389/fonc.2021.637298Read this paper
Datasheet
MSDS
Related products
Product group Antibodies
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry
TargetCCND1
- SizePrice
Product group Antibodies
CCND1 AntibodyCSB-PA001875
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
ReactivityHuman, Mouse, Rat
TargetCCND1
- SizePrice
Product group Antibodies
Goat anti-cyclin D1EB12329
ApplicationsWestern Blot, ELISA
TargetCCND1
- SizePrice
Product group Antibodies
Anti-CCND1 Antibody144-11022
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry
TargetCCND1
- SizePrice
Product group Antibodies
anti-Cyclin D1 (human), Rabbit Monoclonal (RM241)REV-31-1122-00
ApplicationsWestern Blot, ImmunoHistoChemistry
TargetCCND1
- SizePrice
Product group Antibodies
Anti-Cyclin D1/CCND1 Antibody Picoband(r)PB9370-CARRIER-FREE
ApplicationsWestern Blot
TargetCCND1
- SizePrice
Product group Antibodies
Cyclin D1 Polyclonal Antibody, AbBy Fluor-555 ConjugatedBS-20596R-BF555
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
TargetCCND1
- SizePrice
Product group Antibodies
Anti-CCND1 AntibodyAMAB91779
ApplicationsImmunoCytoChemistry
ReactivityHuman
TargetCCND1
- SizePrice